An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts

Journal of Dermatological Treatment

Volumn 14, Issue 4, 2003, Pages 233-236

  Micali, Giuseppe ^a   Dall'Oglio, F ^a   Nasca, M R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Imiquimod 5 cream; Periungual and subungual warts; Topical immunotherapy

Indexed keywords

IMIQUIMOD;

ADOLESCENT; ADULT; ARTICLE; BURNING SENSATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MALE; NAIL INFECTION; PAIN; PRIORITY JOURNAL; PRURITUS; RELAPSE; SIDE EFFECT; TREATMENT OUTCOME; VERRUCA VULGARIS;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AMINOQUINOLINES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMOLLIENTS; FEMALE; FOLLOW-UP STUDIES; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; NAIL DISEASES; SALVAGE THERAPY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WARTS;

EID: 0344873639     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630310016763     Document Type: Article

References (12)

1. Plasencia JM. Cutaneous warts. Dermatology (2000) 2: 423-34.
2. Trofatter KF Jr, Ferenczy A, Fife KH. Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women. Int J Gynaecol Obstet (2002) 76: 191-3.
3. Fife KH, Ferenczy A, Douglas JM et al, The HPV Study Group. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day. Sex Transm Dis (2001) 28: 226-31.
4. Garland SM, Sellors JW, Wikstrom A et al, Imiquimod Study Group. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts. Results of an open-label, multicentre Phase IIIB trial. Int J AIDS (2001) 12: 722-9.
5. Bigby M, At what rates do commonly used local treatments lead to complete disappearance of the treated warts? Arch Dermatol (2003) 139: 801-2.
6. Hengge UR, Esser S, Schultewolter T et al, Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol (2000) 143: 1026-31.
7. Sparling JD, Checketts SR, Chapman MS. Imiquimod for plantar and periungual warts. Cutis (2001) 68: 397-9.
8. Muzio G, Massone C, Rebora A, Treatment of nongenital warts with topical imiquimod 5% cream. Eur J Dermatol (2002) 12: 347-9.
9. Grussendorf-Conen EI, Jacobs S, Rubben A, Dethlefsen U, Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities. Dermatology (2002) 205: 139-45.
10. Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Ped Dermatol (2002) 19: 263-6.
11. Yesudian PD, Parslew RA. Treatment of recalcitrant plantar warts with imiquimod. J Dermatol Treat (2002) 13: 31-3.
12. Micali G, Dall'Oglio F, Tedeschi A et al, Treatment of cutaneous warts with squaric acid dibutylester: a ten year experience. Arch Dermatol (2000) 136: 557-8.